Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid–Producing Microbiota in the Gut
By Jacobo de la Cuesta-Zuluaga, N. Mueller, V. Corrales-Agudelo, Eliana P. Velásquez-Mejía, J. Carmona, J. M. Abad, J. Escobar. Diabetes Care, 2016
657 citations recorded by the source corpus.
Subfields: Infectious Diseases, Molecular Biology, Periodontics
View Paper: https://www.semanticscholar.org/paper/a7ef1b88a7bcb4852425480d7c484651baa014af
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Infectious Diseases
In Molecular Biology
- W. D. de Vos
- Patrice D Cani
- H. Smidt
- Erwin G. Zoetendal
- Jens J. Holst
- Ellen E. Blaak
- Albert K. Groen
- Evgeni Levin
Citations in the corpus
- Next-Generation Beneficial Microbes: The Case of Akkermansia muciniphila (2017, background): “Conversely, antidiabetic treatments, such as metformin administration and bariatric surgery were both found to be associated with a marked increase in the abundance of A. muciniphila (Figure 1) (Shin et al., 2014; Forslund et al., 2015; de la Cuesta-Zuluaga et al., 2017).”
- Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition. (2017, background): “These include the lactate-producing Lactobacillus salivarius (Messaoudi et al., 2013) and butyrate-producing Butyrivibrio (de la Cuesta-Zuluaga et al., 2017), Clostridium symbiosum (O’Keefe et al., 2015), and Eubacterium species (Vrieze et al., 2012; Udayappan et al., 2016).”